Peptide Therapeutics

Optimi CEO says Alberta’s decision to regulate psychedelics and establish a framework is “politically courageous” Highlights: The safe supply of psychedelic drug products manufactured at a GMP-level is critical in treating serious mental health issues. Minister of Mental Health and Addictions, the Honourable Carolyn Bennett, has publicly stated that safe drug supply is paramount to…

𝗦𝘆𝗻𝗼𝗽𝘀𝗶𝘀 𝗼𝗳 𝗧𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 – A new study titled Peptide Therapeutics in Metabolic Disorders Market 2022, published by The Coherent Market Insights, provides information on regional and global markets that is anticipated to increase in value between 2022 and 2028. The extensive research on the global Peptide Therapeutics in Metabolic Disorders Market offers important insights…